Podoplanin is regulated by AP-1 and promotes platelet aggregation and cell migration in osteosarcoma

American Journal of Pathology

Volumn 179, Issue 2, 2011, Pages 1041-1049

  Kunita, Akiko ^a   Kashima, Takeshi G ^a,b   Ohazama, Atsushi ^c   Grigoriadis, Agamemnon E ^b   Fukayama, Masashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; PODOPLANIN; PROTEIN C FOS; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; BONE MATRIX; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; THROMBOCYTE AGGREGATION; TISSUE MICROARRAY; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOSARCOMA; PLATELET AGGREGATION; RNA INTERFERENCE; TRANSCRIPTION FACTOR AP-1; TRANSFORMING GROWTH FACTOR BETA1;

EID: 80052462264     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.04.027     Document Type: Article

References (48)

1. B. Kempf-Bielack, S.S. Bielack, H. Jurgens, D. Branscheid, W.E. Berdel, G.U. Exner, U. Gobel, K. Helmke, G. Jundt, H. Kabisch, M. Kevric, T. Klingebiel, R. Kotz, R. Maas, R. Schwarz, M. Semik, J. Treuner, A. Zoubek, and K. Winkler Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS) J Clin Oncol 23 2005 559 568 (Pubitemid 46224233)
2. J.B. Hayden, and B.H. Hoang Osteosarcoma: basic science and clinical implications Orthop Clin North Am 37 2006 1 7 (Pubitemid 41719081)
3. G.J. Gasic, T.B. Gasic, N. Galanti, T. Johnson, and S. Murphy Platelet-tumor-cell interactions in mice The role of platelets in the spread of malignant disease Int J Cancer 11 1973 704 718
4. P. Mehta Potential role of platelets in the pathogenesis of tumor metastasis Blood 63 1984 55 63 (Pubitemid 14224521)
5. Y. Sugimoto, M. Watanabe, T. Oh-hara, S. Sato, T. Isoe, and T. Tsuruo Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregation Cancer Res 51 1991 921 925
6. Y. Kato, N. Fujita, A. Kunita, S. Sato, M. Kaneko, M. Osawa, and T. Tsuruo Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors J Biol Chem 278 2003 51599 51605 (Pubitemid 38020404)
7. T. Ariizumi, A. Ogose, H. Kawashima, T. Hotta, G. Li, Y. Xu, H. Umezu, M. Sugai, and N. Endo Expression of podoplanin in human bone and bone tumors: new marker of osteogenic and chondrogenic bone tumors Pathol Int 60 2010 193 202
8. V. Schacht, S.S. Dadras, L.A. Johnson, D.G. Jackson, Y.K. Hong, and M. Detmar Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors Am J Pathol 166 2005 913 921 (Pubitemid 40315647)
9. A. Wicki, and G. Christofori The potential role of podoplanin in tumour invasion Br J Cancer 96 2007 1 5 (Pubitemid 46094630)
10. W.Y. Chuang, C.J. Yeh, Y.C. Wu, Y.K. Chao, Y.H. Liu, C.K. Tseng, H.K. Chang, H.P. Liu, and C. Hsueh Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma Histol Histopathol 24 2009 1021 1027
11. M. Kreppel, M. Scheer, U. Drebber, L. Ritter, and J.E. Zoller Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations Virchows Arch 456 2010 473 482
12. A. Wicki, F. Lehembre, N. Wick, B. Hantusch, D. Kerjaschki, and G. Christofori Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton Cancer Cell 9 2006 261 272
13. E. Martin-Villar, D. Megias, S. Castel, M.M. Yurrita, S. Vilaro, and M. Quintanilla Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition J Cell Sci 119 2006 4541 4553 (Pubitemid 44830653)
14. A. Kunita, T.G. Kashima, Y. Morishita, M. Fukayama, Y. Kato, T. Tsuruo, and N. Fujita The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis Am J Pathol 170 2007 1337 1347 (Pubitemid 47339340)
15. J.R. Edwards, K. Williams, L.G. Kindblom, J.M. Meis-Kindblom, P.C. Hogendoorn, D. Hughes, R.G. Forsyth, D. Jackson, and N.A. Athanasou Lymphatics and bone Hum Pathol 39 2008 49 55 (Pubitemid 350216159)
16. D. Guo, and L.F. Bonewald Advancing our understanding of osteocyte cell biology Ther Adv Musculoskel Dis 1 2009 87 96
17. B. Hantusch, R. Kalt, S. Krieger, C. Puri, and D. Kerjaschki Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells BMC Mol Biol 8 2007 20
18. Y. Shen, C.S. Chen, H. Ichikawa, and G.S. Goldberg SRC induces podoplanin expression to promote cell migration J Biol Chem 285 2010 9649 9656
19. M. Durchdewald, J. Guinea-Viniegra, D. Haag, A. Riehl, P. Lichter, M. Hahn, E.F. Wagner, P. Angel, and J. Hess Podoplanin is a novel fos target gene in skin carcinogenesis Cancer Res 68 2008 6877 6883
20. P. Angel, and M. Karin The role of Jun. Fos and the AP-1 complex in cell-proliferation and transformation Biochim Biophys Acta 1072 1991 129 157 (Pubitemid 121007534)
21. E.F. Wagner AP-1Introductory remarks Oncogene 20 2001 2334 2335
22. R. Eferl, and E.F. Wagner AP-1: a double-edged sword in tumorigenesis Nat Rev Cancer 3 2003 859 868 (Pubitemid 37383716)
23. R. Zenz, R. Eferl, C. Scheinecker, K. Redlich, J. Smolen, H.B. Schonthaler, L. Kenner, E. Tschachler, and E.F. Wagner Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease Arthritis Res Ther 10 2008 201
24. A.E. Grigoriadis, K. Schellander, Z.Q. Wang, and E.F. Wagner Osteoblasts are target cells for transformation in c-fos transgenic mice J Cell Biol 122 1993 685 701 (Pubitemid 23226685)
25. D.J. Papachristou, A. Batistatou, G.P. Sykiotis, I. Varakis, and A.G. Papavassiliou Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas Bone 32 2003 364 371 (Pubitemid 36407536)
26. P. Mehta, D. Lawson, M.B. Ward, A. Kimura, and A. Gee Effect of human tumor cells on platelet aggregation: potential relevance to pattern of metastasis Cancer Res 47 1987 3115 3117 (Pubitemid 17082633)
27. A. Sunters, D.P. Thomas, W.A. Yeudall, and A.E. Grigoriadis Accelerated cell cycle progression in osteoblasts overexpressing the c-fos proto-oncogene: induction of cyclin A and enhanced CDK2 activity J Biol Chem 279 2004 9882 9891 (Pubitemid 38372587)
28. T. Asai, T. Ueda, K. Itoh, K. Yoshioka, Y. Aoki, S. Mori, and H. Yoshikawa Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung Int J Cancer 76 1998 418 422 (Pubitemid 28282943)
29. T. Kashima, J. Kawaguchi, S. Takeshita, M. Kuroda, M. Takanashi, H. Horiuchi, T. Imamura, Y. Ishikawa, T. Ishida, S. Mori, R. Machinami, and A. Kudo Anomalous cadherin expression in osteosarcoma Possible relationships to metastasis and morphogenesis Am J Pathol 155 1999 1549 1555
30. S. Ogasawara, M.K. Kaneko, J.E. Price, and Y. Kato Characterization of anti-podoplanin monoclonal antibodies: critical epitopes for neutralizing the interaction between podoplanin and CLEC-2 Hybridoma (Larchmt) 27 2008 259 267
31. T. Kashima, K. Nakamura, J. Kawaguchi, M. Takanashi, T. Ishida, H. Aburatani, A. Kudo, M. Fukayama, and A.E. Grigoriadis Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo Int J Cancer 104 2003 147 154 (Pubitemid 36249788)
32. D.C. Cardinal, and R.J. Flower The electronic aggregometer: a novel device for assessing platelet behavior in blood J Pharmacol 3 1980 135 158 (Pubitemid 10052139)
33. A. Ohazama, E.B. Johnson, M.S. Ota, H.Y. Choi, T. Porntaveetus, S. Oommen, N. Itoh, K. Eto, A. Gritli-Linde, J. Herz, and P.T. Sharpe Lrp4 modulates extracellular integration of cell signaling pathways in development PLoS One 3 2008 e4092
34. M.J. Klein, and G.P. Siegal Osteosarcoma: anatomic and histologic variants Am J Clin Pathol 125 2006 555 581
35. Y. Kato, M.K. Kaneko, A. Kunita, H. Ito, A. Kameyama, S. Ogasawara, N. Matsuura, Y. Hasegawa, K. Suzuki-Inoue, O. Inoue, Y. Ozaki, and H. Narimatsu Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2 Cancer Sci 99 2008 54 61 (Pubitemid 350239031)
36. K.W. Hunter Ezrin, a key component in tumor metastasis Trends Mol Med 10 2004 201 204 (Pubitemid 38581790)
37. S. Tsukita, and S. Yonemura ERM (ezrin/radixin/moesin) family: from cytoskeleton to signal transduction Curr Opin Cell Biol 9 1997 70 75 (Pubitemid 27065111)
38. S. Yonemura, M. Hirao, Y. Doi, N. Takahashi, T. Kondo, S. Tsukita, and S. Tsukita Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44. CD43, and ICAM-2 J Cell Biol 140 1998 885 895 (Pubitemid 28141226)
39. I. Ohizumi, N. Harada, K. Taniguchi, Y. Tsutsumi, S. Nakagawa, S. Kaiho, and T. Mayumi Association of CD44 with OTS-8 in tumor vascular endothelial cells Biochim Biophys Acta 1497 2000 197 203 (Pubitemid 30618831)
40. E. Martin-Villar, B. Fernandez-Munoz, M. Parsons, M.M. Yurrita, D. Megias, E. Perez-Gomez, G.E. Jones, and M. Quintanilla Podoplanin associates with CD44 to promote directional cell migration Mol Biol Cell 21 2010 4387 4399
41. F.G. Scholl, C. Gamallo, S. Vilaro, and M. Quintanilla Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes J Cell Sci 112 1999 4601 4613 (Pubitemid 30034809)
42. C. Khanna, X. Wan, S. Bose, R. Cassaday, O. Olomu, A. Mendoza, C. Yeung, R. Gorlick, S.M. Hewitt, and L.J. Helman The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis Nat Med 10 2004 182 186 (Pubitemid 38524889)
43. B.W. Ozanne, H.J. Spence, L.C. McGarry, and R.F. Hennigan Transcription factors control invasion: aP-1 the first among equals Oncogene 26 2007 1 10 (Pubitemid 46067326)
44. J.A. Uria, M.G. Jimenez, M. Balbin, J.M. Freije, and C. Lopez-Otin Differential effects of transforming growth factor-beta on the expression of collagenase-1 and collagenase-3 in human fibroblasts J Biol Chem 273 1998 9769 9777 (Pubitemid 28183070)
45. S.J. Kim, P. Angel, R. Lafyatis, K. Hattori, K.Y. Kim, M.B. Sporn, M. Karin, and A.B. Roberts Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex Mol Cell Biol 10 1990 1492 1497
46. H. Suzuki, Y. Kato, M.K. Kaneko, Y. Okita, H. Narimatsu, and M. Kato Induction of podoplanin by transforming growth factor-beta in human fibrosarcoma FEBS Lett 582 2008 341 345
47. N. Atsumi, G. Ishii, M. Kojima, M. Sanada, S. Fujii, and A. Ochiai Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431 Biochem Biophys Res Commun 373 2008 36 41
48. N. Tang, W.X. Song, J. Luo, R.C. Haydon, and T.C. He Osteosarcoma development and stem cell differentiation Clin Orthop Relat Res 466 2008 2114 2130